A study protocol for a feasibility trial of telephone-delivered Adherence Therapy for adults with type 2 diabetes

被引:3
作者
Alenazi, Fatimah [1 ,2 ]
Peddle, Monica [3 ]
Bressington, Daniel [4 ,5 ]
Mahzari, Moeber [6 ,7 ,8 ]
Gray, Richard [9 ]
机构
[1] La Trobe Univ, Coll Sci Hlth & Engn, Bundoora, Vic 3086, Australia
[2] Qassim Univ, Coll Publ Hlth & Hlth Informat, Dept Publ Hlth, Albukayriyah, Saudi Arabia
[3] La Trobe Univ, Coll Sci Hlth & Engn, Sch Nursing & Midwifery, Nursing, Melbourne, Vic, Australia
[4] Hong Kong Polytech Univ, Sch Nursing, Kowloon, Hong Kong, Peoples R China
[5] Charles Darwin Univ, Coll Nursing & Midwifery, Bundoora, Vic, Australia
[6] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Med Endocrinol, Riyadh, Ksa, Saudi Arabia
[7] Minist Natl Guard Hlth Affairs, Div Endocrinol, Dept Med, Riyadh, Ksa, Saudi Arabia
[8] King Abdullah Int Med Res Ctr, Riyadh, Ksa, Saudi Arabia
[9] La Trobe Univ, Clin Nursing Practice, Melbourne, Vic, Australia
来源
NURSING OPEN | 2021年 / 8卷 / 03期
关键词
diabetes; feasibility study; nurses; nursing; protocol; telephone-delivered adherence therapy; MEDICATION ADHERENCE; CLINICAL-OUTCOMES; SCHIZOPHRENIA; BELIEFS; NONADHERENCE; MANAGEMENT; PATIENT; PEOPLE;
D O I
10.1002/nop2.735
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Aims Adherence therapy is a candidate intervention to improve medication adherence and clinical outcomes in patients with type 2 diabetes. The feasibility of conducting a trial of adherence therapy in this population has not been established. The objective of this study is therefore to test the feasibility of conducting a randomized controlled trial of adherence therapy in a Middle Eastern context. Design A single-centre randomized controlled feasibility trial of adherence therapy in patients with type 2 diabetes. Methods We will undertake an initial cultural adaptation of a telephone-delivered form of adherence therapy in four patients in a Middle Eastern context. Our subsequent feasibility trial will aim to recruit 40 non-adherent diabetic patients that will be randomly allocated to receive eight weekly 30-min telephone adherence therapy sessions delivered by a diabetes educator versus treatment as usual. Key outcomes of interest include the number of patients invited to take part in the trial that consent to participate and then go on to complete treatment. Result The findings of this study will determine the feasibility of undertaking a full randomized controlled trial of adherence therapy in patients with type 2 diabetes.
引用
收藏
页码:1510 / 1519
页数:10
相关论文
共 45 条
  • [1] Adherence therapy for medication non-compliant patients with hypertension: a randomised controlled trial
    Alhalaiqa, F.
    Deane, K. H. O.
    Nawafleh, A. H.
    Clark, A.
    Gray, R.
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2012, 26 (02) : 117 - 126
  • [2] Validity of Arabic Version of Beliefs About Medication Questionnaire
    Alhalaiqa, Fadwa
    Masa'Deh, Rami
    Batiha, Abdul-Monim
    Deane, Katherine
    [J]. CLINICAL NURSING RESEARCH, 2015, 24 (05) : 539 - 555
  • [3] Hypertensive patients' experience with adherence therapy for enhancing medication compliance: a qualitative exploration
    Alhalaiqa, Fadwa
    Deane, Katherine H. O.
    Gray, Richard
    [J]. JOURNAL OF CLINICAL NURSING, 2013, 22 (13-14) : 2039 - 2052
  • [4] Patients' management of type 2 diabetes in Middle Eastern countries: review of studies
    Alsairafi, Zahra Khalil
    Taylor, Kevin Michael Geoffrey
    Smith, Felicity J.
    Alattar, Abdulnabi T.
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2016, 10 : 1051 - 1062
  • [5] ALSOUS M, 2017, PLOS ONE, V12
  • [6] [Anonymous], 2006, National Chronic Disease Strategy
  • [7] What is a pilot or feasibility study? A review of current practice and editorial policy
    Arain, Mubashir
    Campbell, Michael J.
    Cooper, Cindy L.
    Lancaster, Gillian A.
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2010, 10
  • [8] Australian clinical trial handbook (AU), 2018, THER GOODS ADM TGA
  • [9] Factors related to high and low levels of drug adherence according to patients with type 2 diabetes
    Borgsteede, Sander D.
    Westerman, Marjan J.
    Kok, Irene L.
    Meeuse, Joke C.
    de Vries, Theo P. G. M.
    Hugtenburg, Jacqueline G.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (05) : 779 - 787
  • [10] Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI DOI 10.1191/1478088706QP063OA